Quick Takeaways
- ONC - BeOne Medicines Ltd. has 24 insiders with reported activity on this page.
- Net insider value flow over the last year: -$136,312,175.
- Recent transaction rows are available for direct filing-level review.
- Info
- Significant Ownership
- Insider Ownership
- Insider Trading
- Financials
- Holders
Insider Transactions Reported by 24 Insiders of BeOne Medicines Ltd.
- Symbol
- ONC on Nasdaq, BEIGF on OTC
- Location
- Basel
What Changed
- Buy value: ; sell value: $136,312,174.
- Net share flow: -470,801.
Why This Matters
- This page gives a plain-language issuer insider context before you inspect transaction-level evidence.
- Use the filing links below to verify timestamps, codes, and ownership impacts directly from SEC forms.
Official SEC Source
Insider trading overview
Last 12 monthsNet insider flow leans to selling over the last 12 months. Net value: -$136,312,175.
Buys
$0
Shares: 0
Insiders: 0
Sells
$136,312,175
Shares: 470,801
Insiders: 8
Net
-$136,312,175
Shares: -470,801
Insiders: -8
| Window (months) | Buy shares | Sell shares | Buy $ | Sell $ | Net $ |
|---|---|---|---|---|---|
| 0-3 | 0 | 2,333 | $0 | $785,944 | -$785,944 |
| 3-6 | 0 | 124,951 | $0 | $39,701,704 | -$39,701,704 |
| 6-9 | 0 | 164,184 | $0 | $51,534,152 | -$51,534,152 |
| 9-12 | 0 | 179,333 | $0 | $44,290,375 | -$44,290,375 |
BeOne Medicines Ltd. executives and other stock owners filed with the SEC include:
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 10%+ Owner | $25,009,148,200 | Filing P/S | 02 Dec 2024 | ||
| AMGEN INC | 10%+ Owner | $3,419,356,261 | Mixed | 10 Sep 2021 | ||
| BAKER BROS. ADVISORS LP | Director | $2,136,757,882 | Mixed | 21 May 2025 | ||
| John Oyler | Chief Executive Officer, Director | $2,021,400,984 | -$50,239,529 | -2.4% | Mixed | 06 Mar 2026 |
| Xiaodong Wang | Director, Chair, Scientific Advisory Brd | $1,561,309,195 | -$30,975,050 | -1.9% | Mixed | 07 Nov 2025 |
| Lai Wang | President, Global Head of R&D | $786,064,813 | -$4,314,519 | -0.55% | Mixed | 06 Mar 2026 |
| Donald W. Glazer | Director | $564,671,459 | Mixed | 05 Jun 2024 | ||
| Xiaobin Wu | President and COO | $431,687,347 | -$36,124,471 | -7.7% | Mixed | 06 Mar 2026 |
| Howard Liang | CFO & Chief Strategy Officer | $322,615,606 | Mixed | 28 Jun 2021 | ||
| Aaron Rosenberg | Chief Financial Officer | $118,534,532 | -$345,659 | -0.29% | Mixed | 06 Mar 2026 |
| Chan Henry Lee | SVP, General Counsel | $94,571,808 | -$12,444,821 | -12% | Mixed | 08 Apr 2026 |
| Julia Aijun Wang | Chief Financial Officer | $88,611,076 | Mixed | 01 Jul 2024 | ||
| Jane Huang | CMO, Hematology | $33,246,160 | Mixed | 14 Dec 2021 | ||
| Titus B. Ball | Principal Accounting Officer | $22,262,801 | -$74,485 | -0.33% | Mixed | 02 Sep 2025 |
| Corazon (corsee) D. Sanders | Director | $17,741,776 | -$1,793,639 | -9.2% | Mixed | 26 Nov 2025 |
| Anthony C. Hooper | Director | $15,854,826 | Mixed | 21 May 2025 | ||
| Thomas Malley | Director | $15,114,558 | Mixed | 15 Jun 2023 | ||
| Alessandro Riva | Director | $13,944,606 | Mixed | 21 May 2025 | ||
| Margaret Dugan | Director | $13,944,606 | Mixed | 21 May 2025 | ||
| Olivier Brandicourt | Director | $6,692,137 | Mixed | 21 May 2025 | ||
| Qingqing Yi | Director | $6,373,789 | Mixed | 10 Jun 2025 | ||
| Shalini Sharp | Director | $4,686,406 | Mixed | 21 May 2025 | ||
| Timothy Yung-Cheng Chen | Director | $1,620,193 | Mixed | 16 Jun 2021 | ||
| Jingshyh S. Su | Director | $1,620,193 | Mixed | 16 Jun 2021 |
Top shareholders of BeOne Medicines Ltd. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. |
3/4/5
13D/G
13F
|
10%+ Owner · Company |
4.9%
from 13D/G
|
125,045,741
|
$25,009,148,200 | — | 02 Dec 2024 | |
| AMGEN INC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
18,943,802
|
$3,419,356,261 | — | 10 Sep 2021 | |
| BAKER BROS. ADVISORS LP |
13F
3/4/5
|
Company · Director |
0.64%
|
8,799,053
|
$2,673,240,292 | — | 31 Dec 2025 | |
| John Oyler |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
6,059,837
mixed-class rows
|
$2,021,400,984 | -$50,239,529 | 06 Mar 2026 | |
| Xiaodong Wang |
3/4/5
|
Director, Chair, Scientific Advisory Brd |
—
mixed-class rows
|
4,582,658
mixed-class rows
|
$1,561,309,195 | -$30,975,050 | 07 Nov 2025 | |
| Capital International Investors |
13F
13D/G
|
Company |
5.8%
from 13D/G
|
5,113,866
|
$1,553,909,094 | — | 31 Dec 2025 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
0.36%
|
4,980,581
|
$1,513,150,314 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.29%
|
3,992,627
|
$1,213,000,071 | — | 31 Dec 2025 | |
| Lai Wang |
3/4/5
|
President, Global Head of R&D |
—
mixed-class rows
|
2,383,589
mixed-class rows
|
$786,064,813 | -$4,314,519 | 06 Mar 2026 | |
| Donald W. Glazer |
3/4/5
|
Director |
—
mixed-class rows
|
2,752,615
mixed-class rows
|
$564,671,459 | — | 05 Jun 2024 | |
| Xiaobin Wu |
3/4/5
|
President and COO |
—
mixed-class rows
|
1,590,935
mixed-class rows
|
$431,687,347 | -$36,124,471 | 06 Mar 2026 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.1%
|
1,372,679
|
$417,034,000 | — | 31 Dec 2025 | |
| Howard Liang |
3/4/5
|
CFO & Chief Strategy Officer |
—
class O/S missing
|
1,553,149
|
$322,615,606 | — | 28 Jun 2021 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.07%
|
919,587
|
$279,379,726 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.05%
|
676,210
|
$205,439,150 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.04%
|
533,517
|
$162,087,800 | — | 31 Dec 2025 | |
| Siren, L.L.C. |
13F
|
Individual |
0.04%
|
500,000
|
$151,905,000 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
437,661
|
$132,966,412 | — | 31 Dec 2025 | |
| Aaron Rosenberg |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
454,792
mixed-class rows
|
$118,534,532 | -$345,659 | 06 Mar 2026 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
378,832
|
$115,093,010 | — | 31 Dec 2025 | |
| Chan Henry Lee |
3/4/5
|
SVP, General Counsel |
—
mixed-class rows
|
427,492
mixed-class rows
|
$94,571,808 | -$12,444,821 | 08 Apr 2026 | |
| Capital International, Inc./CA/ |
13F
|
Company |
0.02%
|
307,660
|
$93,470,185 | — | 31 Dec 2025 | |
| Baird Financial Group, Inc. |
13F
|
Company |
0.02%
|
304,339
|
$92,461,232 | — | 31 Dec 2025 | |
| Julia Aijun Wang |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
683,254
mixed-class rows
|
$88,611,076 | — | 01 Jul 2024 | |
| Man Group plc |
13F
|
Company |
0.02%
|
248,514
|
$75,501,038 | — | 31 Dec 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.01%
|
197,261
|
$59,932,416 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.01%
|
194,124
|
$58,976,812 | — | 31 Dec 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.01%
|
193,951
|
$58,924,253 | — | 31 Dec 2025 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.01%
|
165,241
|
$50,201,868 | — | 31 Dec 2025 | |
| Capital International Sarl |
13F
|
Company |
0.01%
|
152,515
|
$46,335,582 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.01%
|
152,296
|
$46,269,049 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
152,087
|
$46,205,551 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
148,714
|
$45,180,800 | — | 31 Dec 2025 | |
| M&G Plc |
13F
|
Company |
0.01%
|
129,791
|
$39,456,464 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.01%
|
125,825
|
$38,226,893 | — | 31 Dec 2025 | |
| Jane Huang |
3/4/5
|
CMO, Hematology |
—
mixed-class rows
|
371,331
mixed-class rows
|
$33,246,160 | — | 14 Dec 2021 | |
| Jain Global LLC |
13F
|
Company |
0.01%
|
97,335
|
$29,571,346 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.01%
|
94,848
|
$28,815,771 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.01%
|
94,594
|
$28,738,603 | — | 31 Dec 2025 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.01%
|
90,010
|
$27,346,000 | — | 31 Dec 2025 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.01%
|
76,438
|
$23,222,630 | — | 31 Dec 2025 | |
| Titus B. Ball |
3/4/5
|
Principal Accounting Officer |
0.01%
|
72,397
|
$22,262,801 | -$74,485 | 02 Sep 2025 | |
| Patient Square Capital LP |
13F
|
Company |
0.01%
|
69,312
|
$21,057,679 | — | 31 Dec 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0%
|
68,900
|
$20,932,509 | — | 31 Dec 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
67,992
|
$20,656,000 | — | 31 Dec 2025 | |
| CAPITAL INTERNATIONAL LTD /CA/ |
13F
|
Company |
0%
|
67,722
|
$20,574,621 | — | 31 Dec 2025 | |
| Woodline Partners LP |
13F
|
Company |
0%
|
66,985
|
$20,350,713 | — | 31 Dec 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
60,656
|
$18,427,900 | — | 31 Dec 2025 | |
| Corazon (corsee) D. Sanders |
3/4/5
|
Director |
0%
|
57,226
|
$17,741,776 | -$1,793,639 | 26 Nov 2025 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
56,366
|
$17,124,668 | — | 31 Dec 2025 |
Recent Insider Transactions by Companies or Individuals for BeOne Medicines Ltd.
Showing up to 300 most recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $103,448 | $311.59 | -332 | 0 | 08 Apr 2026 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 332 | 332 | 08 Apr 2026 | Direct | |||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -16.9% | -4,316 | 21,177 | 08 Apr 2026 | Direct | ||
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $102,300 | $300.00 | -341 | 0 | 11 Mar 2026 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 341 | 341 | 11 Mar 2026 | Direct | |||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -16.5% | -4,433 | 22,490 | 11 Mar 2026 | Direct | ||
| John Oyler | ONC | Ordinary Shares | Award | 8.62% | 444,912 | 5,609,275 | 06 Mar 2026 | Direct | ||
| Chan Henry Lee | ONC | Ordinary Shares | Award | 42.7% | 95,264 | 318,370 | 06 Mar 2026 | Direct | ||
| Lai Wang | ONC | Ordinary Shares | Award | 11.6% | 167,635 | 1,619,059 | 06 Mar 2026 | Direct | ||
| Xiaobin Wu | ONC | Ordinary Shares | Award | 25.6% | 247,546 | 1,216,524 | 06 Mar 2026 | Direct | ||
| Aaron Rosenberg | ONC | Ordinary Shares | Award | 55.5% | 119,587 | 334,919 | 06 Mar 2026 | Direct | ||
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $580,197 | $349.52 | -1,660 | 0 | 04 Feb 2026 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 1,660 | 1,660 | 04 Feb 2026 | Direct | |||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -47.4% | -21,580 | 23,920 | 04 Feb 2026 | Direct | ||
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $220,289 | $331.76 | -664 | 0 | 07 Jan 2026 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 664 | 664 | 07 Jan 2026 | Direct | |||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -22.1% | -8,632 | 30,446 | 07 Jan 2026 | Direct | ||
| Lai Wang | ONC | Ordinary Shares | Award | 41.8% | 427,895 | 1,451,424 | 31 Dec 2025 | Direct | ||
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $7,380,739 | $302.87 | -24,369 | 0 | 16 Dec 2025 | Direct |
| John Oyler | ONC | American Depositary Shares | Sale | -75.6% | $23,278,679 | $307.79 | -75,631 | 24,369 | 15 Dec 2025 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $107,900 | $325.00 | -332 | 0 | 11 Dec 2025 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 332 | 332 | 11 Dec 2025 | Direct | |||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -11.5% | -4,316 | 33,072 | 11 Dec 2025 | Direct | ||
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $105,669 | $318.28 | -332 | 0 | 10 Dec 2025 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 332 | 332 | 10 Dec 2025 | Direct | |||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -11.2% | -4,316 | 34,385 | 10 Dec 2025 | Direct | ||
| Corazon (corsee) D. Sanders | ONC | American Depositary Shares | Sale | -100% | $895,534 | $340.90 | -2,627 | 0 | 26 Nov 2025 | Direct |
| Corazon (corsee) D. Sanders | ONC | American Depositary Shares | Options Exercise | 2,627 | 2,627 | 26 Nov 2025 | Direct | |||
| Corazon (corsee) D. Sanders | ONC | Share Option (Right to Buy) | Options Exercise | -100% | -34,151 | 0 | 26 Nov 2025 | Direct | ||
| Xiaobin Wu | ONC | American Depositary Shares | Sale | -100% | $1,518,303 | $380.43 | -3,991 | 0 | 17 Nov 2025 | Direct |
| Xiaobin Wu | ONC | American Depositary Shares | Sale | -100% | $2,286,660 | $380.54 | -6,009 | 0 | 13 Nov 2025 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $347,770 | $349.17 | -996 | 0 | 12 Nov 2025 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 996 | 996 | 12 Nov 2025 | Direct | |||
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -26.6% | -12,948 | 35,698 | 12 Nov 2025 | Direct | ||
| Xiaobin Wu | ONC | American Depositary Shares | Sale | -62.5% | $3,560,161 | $356.02 | -10,000 | 6,009 | 12 Nov 2025 | Direct |
| John Oyler | ONC | Ordinary Shares | Gift | -11.8% | -858,533 | 6,441,041 | 12 Nov 2025 | Direct | ||
| John Oyler | ONC | Ordinary Shares | Gift | -2.03% | -151,320 | 7,299,574 | 11 Nov 2025 | Direct | ||
| Xiaodong Wang | ONC | Ordinary Shares | Gift | -8.47% | -424,073 | 4,582,601 | 07 Nov 2025 | Direct | ||
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 9,559 | 9,559 | 08 Oct 2025 | Direct | |||
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $3,739,108 | $350.40 | -10,671 | 0 | 08 Oct 2025 | Direct |
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -75.8% | -124,267 | 39,624 | 08 Oct 2025 | Direct | ||
| John Oyler | ONC | American Depositary Shares | Sale | -100% | $9,055,694 | $325.71 | -27,803 | 0 | 16 Sep 2025 | Direct |
| Chan Henry Lee | ONC | American Depositary Shares | Options Exercise | 8,894 | 8,894 | 10 Sep 2025 | Direct | |||
| Chan Henry Lee | ONC | American Depositary Shares | Sale | -100% | $3,257,289 | $325.53 | -10,006 | 0 | 10 Sep 2025 | Direct |
| Chan Henry Lee | ONC | Share Option (Right to Buy) | Options Exercise | -72.6% | -115,622 | 43,550 | 10 Sep 2025 | Direct | ||
| Xiaodong Wang | ONC | Ordinary Shares | Gift | -2.87% | -148,096 | 5,006,674 | 09 Sep 2025 | Direct | ||
| Lai Wang | ONC | American Depositary Shares | Sale | -100% | $1,750,312 | $350.06 | -5,000 | 0 | 09 Sep 2025 | See Footnote |
| Corazon (corsee) D. Sanders | ONC | American Depositary Shares | Sale | -100% | $898,105 | $337.00 | -2,665 | 0 | 05 Sep 2025 | Direct |
| Corazon (corsee) D. Sanders | ONC | American Depositary Shares | Options Exercise | 2,665 | 2,665 | 05 Sep 2025 | Direct | |||
| Corazon (corsee) D. Sanders | ONC | Share Option (Right to Buy) | Options Exercise | -100% | -34,645 | 0 | 05 Sep 2025 | Direct |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.